-
Publication Date2015-10
Independent Poor Prognostic Factors for True Progression after Radiation Therapy and Concomitant Temozolomide in Patients with Glioblastoma: Subependymal Enhancement and Low ADC Value
R.-E. Yoo; Seung Hong Choi; Kim, TM, et al
AMERICAN JOURNAL OF NEURORADIOLOGY, v.36, no.10, pp.1846 - 1852
-
Publication Date2019-09
Prediction of IDH genotype in gliomas with dynamic susceptibility contrast perfusion MR imaging using an explainable recurrent neural network
Choi, KS; Seung Hong Choi; Jeong, B
NEURO-ONCOLOGY, v.21, no.9, pp.1197 - 1209
-
Publication Date2014-11
Prognosis Prediction of Measurable Enhancing Lesion after Completion of Standard Concomitant Chemoradiotherapy and Adjuvant Temozolomide inGlioblastoma Patients: Application of Dynamic Susceptibility ContrastPerfusion and Diffusion-Weighted Imaging
Kim, JH; Seung Hong Choi; Ryoo, I, et al
PLOS ONE, v.9, no.11, pp.e113587
-
Publication Date2017-03
Prognosis prediction of non-enhancing T2 high signal intensity lesions in glioblastoma patients after standard treatment: application of dynamic contrast-enhanced MR imaging
Rihyeon Kim; Seung Hong Choi; Tae Jin Yun, et al
EUROPEAN RADIOLOGY, v.27, no.3, pp.1176 - 1185
-
Publication Date2022-08
Review and consensus recommendations on clinical APT-weighted imaging approaches at 3T: Application to brain tumors
Highly Cited Paper
Zhou, Jinyuan; Zaiss, Moritz; Knutsson, Linda, et al
MAGNETIC RESONANCE IN MEDICINE, v.88, no.2, pp.546 - 574